The renewed battle against RAS-mutant cancers.

Abstract excerpt

The RAS genes encode for members of a large superfamily of guanosine-5'-triphosphate (GTP)-binding proteins that control diverse intracellular signaling pathways to promote cell proliferation. Somatic mutations in the RAS oncogenes are the most common activating lesions found in human cancers. These mutations invariably result in the gain-of-function of RAS by impairing GTP hydrolysis and are frequently...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Autophagy
• Share to Cancer Genomics and Diagnostics
• Share to Cell Transformation, Neoplastic